Does hepatic steatosis impact chronic hepatitis B?

Terry Cheuk-Fung Yip^{1

2}, Vincent Wai-Sun Wong^{1

2}, Grace Lai-Hung Wong^{1

2}

Affiliations

¹ Medical Data Analytics Center, Department of Medicine and Therapeutics , The Chinese University of Hong Kong , Hong Kong , China.
² State Key Laboratory of Digestive Disease, Institute of Digestive Disease , The Chinese University of Hong Kong , Hong Kong , China.

Editorial

Terry Cheuk-Fung Yip et al. Hepatology. 2023.

. 2023 May 1;77(5):1478-1481.

doi: 10.1002/hep.32803. Epub 2023 Apr 17.

Terry Cheuk-Fung Yip^{1

2}, Vincent Wai-Sun Wong^{1

2}, Grace Lai-Hung Wong^{1

2}

¹ Medical Data Analytics Center, Department of Medicine and Therapeutics , The Chinese University of Hong Kong , Hong Kong , China.
² State Key Laboratory of Digestive Disease, Institute of Digestive Disease , The Chinese University of Hong Kong , Hong Kong , China.

No abstract available

Comment on

Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
Mao X, Cheung KS, Peng C, Mak LY, Cheng HM, Fung J, Peleg N, Leung HH, Kumar R, Lee JH, Shlomai A, Yuen MF, Seto WK. Mao X, et al. Hepatology. 2023 May 1;77(5):1735-1745. doi: 10.1002/hep.32792. Epub 2023 Apr 17. Hepatology. 2023. PMID: 36111362

1. GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7:796–829.
1. Yip TC, Vilar‐Gomez E, Petta S, Yilmaz Y, Wong GL, Adams LA, de Ledinghen V, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology. 2022 Sep 5. https://doi.org/10.1002/hep.32774 . [Epub ahead of print] - DOI
1. Mao X, Cheung KS, Peng C, Mak LY, Cheng HM, Fung J, et al. Steatosis, HBV‐related hepatocellular carcinoma, cirrhosis & HBsAg seroclearance: a systematic review and meta‐analysis. Hepatology. 2022 Sep 15. https://doi.org/10.1002/hep.32792 . [Epub ahead of print] - DOI
1. Yip TC, Chan HL, Tse YK, Lam KL, Lui GC, Wong VW, et al. On‐treatment improvement of MELD score reduces death and hepatic events in patients with hepatitis B‐related cirrhosis. Am J Gastroenterol. 2018;113:1629–38.
1. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, et al. Nonalcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–48.